Number of respondents by (selected*) first cancer site and date of diagnosis: Fee-For-Service

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 42,497 12,966 30.51 6,178 14.54 6,478 15.24 9,532 22.43 7,343 17.28
Breast 41,611 14,354 34.50 5,229 12.57 5,698 13.69 7,907 19.00 8,423 20.24
Lung and Bronchus 22,814 16,982 74.44 2,684 11.76 1,387 6.08 1,189 5.21 572 2.51
Colorectal 21,881 9,751 44.56 3,007 13.74 2,716 12.41 3,404 15.56 3,003 13.72
Melanoma Skin 16,270 6,887 42.33 2,195 13.49 2,129 13.09 2,582 15.87 2,477 15.22
Bladder 12,694 6,195 48.80 1,818 14.32 1,573 12.39 1,783 14.05 1,325 10.44
Non-Hodgkins Lymphoma 9,269 4,634 49.99 1,291 13.93 1,140 12.30 1,304 14.07 900 9.71
Uterine Corpus 6,972 2,406 34.51 864 12.39 873 12.52 1,235 17.71 1,594 22.86
Kidney/Renal Pelvis 6,864 3,346 48.75 935 13.62 865 12.60 1,016 14.80 702 10.23
Head/Neck 6,062 2,816 46.45 851 14.04 768 12.67 893 14.73 734 12.11
Leukemia 5,952 3,339 56.10 850 14.28 652 10.95 698 11.73 413 6.94
Pancreas 4,508 3,956 87.76 337 7.48 94 2.09 80 1.77 41 0.91
Stomach 2,581 1,737 67.30 299 11.58 179 6.94 220 8.52 146 5.66
Ovary 2,466 1,283 52.03 352 14.27 252 10.22 260 10.54 319 12.94
Liver/Bile Duct 2,242 1,751 78.10 247 11.02 120 5.35 94 4.19 30 1.34
Esophagus 1,574 1,136 72.17 196 12.45 100 6.35 86 5.46 56 3.56
Uterine Cervix 809 234 28.92 92 11.37 82 10.14 141 17.43 260 32.14

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 23 Feb, 2023